Home > Healthcare > Biotechnology > Biotechnology R&D > Biological Sample Collection Kits Market

Biological Sample Collection Kits Market Analysis

  • Report ID: GMI6002
  • Published Date: Jul 2024
  • Report Format: PDF

Biological Sample Collection Kits Market Analysis

Based on product, the market is categorized into swabs, viral transport media, blood collection kits, urine collection kits, and other products. The swabs segment generated the highest revenue of USD 2.2 billion in 2023.
 

  • Swabs are user-friendly and minimally invasive compared to more complex sample collection methods, such as blood draws. This ease of use makes them ideal for widespread screening and at-home testing.
     
  • Additionally, swabs are versatile tools used for collecting samples from various body sites, including oral, nasal, vaginal, and wound areas. Their broad application in diagnostics further drives their demand in the market.
     

Based on application, the biological sample collection kits market is classified into diagnostics, and research. The diagnostics segment dominated the market in 2023 with a market share of 78.8%.
 

  • The increasing prevalence of chronic diseases such as diabetes, cardiovascular conditions, and cancer necessitates regular monitoring and diagnostic testing. This ongoing need for disease management drives substantial demand for diagnostic tests.
     
  • Additionally, early detection through routine diagnostics improves management and treatment outcomes, further underscoring the critical role of these tests in effective healthcare.
     
Biological Sample Collection Kits Market, By End-use (2023)

Based on end-use, the biological sample collection kits market is classified into hospitals and clinics, diagnostic centers, homecare, and other end-users. The hospitals and clinics segment dominated the market and is expected to grow at a pace of 8.7% CAGR between 2024 – 2032.
 

  • Hospitals and clinics experience a high volume of patient visits for a range of health issues, including acute and chronic conditions, routine check-ups, surgeries, and emergencies. This generates a continuous and significant demand for biological sample collection kits.
     
  • Additionally, the provision of both inpatient and outpatient services in these facilities addresses a diverse range of diagnostic and therapeutic needs, ensuring a steady requirement for sample collection kits for both immediate and scheduled testing.
     
North America Biological Sample Collection Kits Market, 2021- 2032 (USD Billion)

North America biological sample collection kits market accounted for USD 2.7 billion market revenue in 2023 and is anticipated to grow at CAGR of 8.1% between 2024 – 2032 period.
 

  • North America has a high prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer. Regular monitoring and diagnostic testing for these conditions drive the demand for sample collection kits.
     
  • For instance, according to the Centers for Disease Control and Prevention (CDC), as of 2020, approximately 34.2 million Americans had diabetes. Increase in prevalence of such conditions is driving the market growth in the region.
     

The U.S. held a dominant position in the biological sample collection kits market, with a revenue of USD 2.5 billion in 2023.
 

  • Increased awareness and emphasis on preventive healthcare in the country lead to more routine screenings and early detection programs, requiring various sample collection kits.
     
  • Moreover, public health campaigns and initiatives promoting regular health check-ups and screenings contribute to the rising demand for diagnostic testing supplies.
     

Germany biological sample collection kits market is projected to grow remarkably in the coming years.
 

  • Germany has a well-developed healthcare infrastructure with numerous hospitals, clinics, and diagnostic centers that require a steady supply of sample collection kits.
     
  • Additionally, regulatory agencies like the European Medicines Agency (EMA) and national bodies provide clear guidelines and approvals for diagnostic tests and sample collection kits, ensuring market growth and trust in these products.
     

Japan holds a dominant position in the Asia Pacific biological sample collection kits market.
 

  • Japan is a leading hub for biomedical research and clinical trials, which require extensive use of biological sample collection kits for various studies.
     
  • Additionally, numerous academic and research institutions involved in cutting-edge research drive the demand for specialized sample collection kits.
     
Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global biological sample collection kits industry was valued at USD 8.4 billion in 2023 and is expected to exhibit a CAGR of 8.8% from 2024 to 2032, driven by the increasing number of laboratory tests, fueled by rising chronic and infectious disease prevalence.

The hospitals and clinics segment is expected to grow at a pace of 8.7% between 2024-2032, as these settings experience a high volume of patient visits for a range of health issues, including acute and chronic conditions, routine check-ups, surgeries, and emergencies.

North America biological sample collection kits market accounted for USD 2.7 billion in 2023 and is anticipated to record a CAGR of 8.1% through 2032, owing to a high prevalence of chronic diseases, along with focus on regular monitoring and diagnostic testing.

Altona Diagnostics GmbH, Becton, Dickinson and Company, CTK Biotech, Inc., F. Hoffmann-La Roche Ltd, Hardy Diagnostics, HiMedia Laboratories, Laboratory Corporation of America Holdings, Lucence Health Inc., and Puritan Medical Products among others.

Biological Sample Collection Kits Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 159
  • Countries covered: 23
  • Pages: 100
 Download Free Sample